Gujarat Themis Biosyn Ltd. is a company located in Valsad, Gujarat, India. It was incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. The company started production in August 1985, specializing in the production of Erythromycin and Erythromycin salts and formulations. In June 1991, it was taken over by Pharmaceutical Business Group (India) Ltd. (PBG), which is a consortium of five competing drug companies. Gujarat Themis Biosyn Ltd. entered into a technical and financial collaboration with Yuhan Corporation, South Korea, becoming India's first company to start commercial production of the anti-tuberculosis drug Rifampicin. The company's main product is Rifamycin-S, an intermediate for "Rifampicin" used in the treatment of tuberculosis (TB). The company's registered address and works are located in Vapi, Gujarat, and it also has a contact office in Mumbai, Maharashtra.
Legal Address
Plot NO. 69-C, G.I.D.C.,, Industrial Estate, Vapi
Valsad; Gujarat;
Postal Code: 396195
Contact Details: Purchase the Gujarat Themis Biosyn Ltd. report to view the information.
Website: http://www.gtbl.in
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service